| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 28, 2026 | Sell(S) | 1K | $2.80 | $3K | 33K |
| Aug 27, 2026 | Sell(S) | 1K | $2.85 | $4K | 34K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 16, 2026 | Grant(A) | 5K | — | $0 | 18K |
| Mar 16, 2025 | Grant(A) | 4K | — | $0 | 13K |
| Mar 18, 2024 | Grant(A) | 3K | — | $0 | 9K |
| Mar 21, 2023 | Grant(A) | 2K | — | $0 | 7K |
| Mar 7, 2022 | Grant(A) | 2K | — | $0 | 5K |
| Apr 19, 2021 | Grant(A) | 3K | — | $0 | 3K |
| Jul 16, 2020 | Grant(A) | 172 | — | $0 | 172 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-26-004371) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Chemomab Therapeutics Ltd.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001178913-26-004371"
Use Arkolith to summarize insider buying and selling at Chemomab Therapeutics Ltd. over the last 90 days and cite the filings.